# Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes

> **NCT00803530** · PHASE2 · TERMINATED · sponsor: **Fondazione Italiana Sindromi Mielodisplastiche-ETS** · enrollment: 55 (estimated)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** ATO + Ascorbic acid

## Key facts

- **NCT ID:** NCT00803530
- **Lead sponsor:** Fondazione Italiana Sindromi Mielodisplastiche-ETS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** 2007-01
- **Final completion:** 2010-08
- **Target enrollment:** 55 (ESTIMATED)
- **Why stopped:** difficulties of enrollement
- **Last updated:** 2011-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00803530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00803530, "Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00803530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*